Gilead $246.75 Million Settlement for HIV Drug Overcharges

Published

January 11, 2024 3:55 PM

Updated

June 23, 2024

Settlement Open for Claims

Award:

Varies depending on the number of valid claims filed

Deadline:

January 1, 2024

SUBMIT CLAIM

Notice Letter

Status

Closed

Category

Antitrust

Settlement Amount

$246,750,000

Award

Varies depending on the number of valid claims filed

Is Proof Required?

Proof Required

Days Remaining to file Claim

Claim Deadline

January 1, 2024

Fairness Hearing

January 18, 2024

Final Approval Hearing

Case Number

20-cv-06961-EMC and 19-cv-02573-EMC

Case Title

KPH Healthcare Services, Inc. v. Gilead Sciences, Inc., No. 3:20-cv-06961-EMC (N.D. Cal.), coordinated with In re HIV Antitrust Litigation (formerly called Staley v. Gilead Sciences, Inc.), No. 3:19-cv-02573-EMC (N.D. Cal.)

State

Court

Jurisdiction

Settlement Website

http://www.hivdirectpurchaserclass.com/

Claims Administrator

Direct Purchaser Truvada/Atripla Antitrust Settlement Claims Administrator P.O. Box 990 Corte Madera, CA 94976-0990 1-501-821-5575 info@HIVDirectPurchaserClass.com

Class Counsel

No items found.